ECG Regression Model for LQT1 LQT2 Mutation Differentiation

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current methods for differentiating between KvLQT1 and HERG mutations in patients with Long QT Syndrome are costly, time-consuming, and unreliable, as they rely on genetic testing, which is not feasible for all patients due to high expenses and prolonged processing times.

Innovation Solution

An ECG-based system and method that uses regression models to differentiate between LQT1 and LQT2 mutations by analyzing specific ECG parameters such as T-wave slopes, T-wave magnitude, and repolarization morphology, allowing for quicker and more economical identification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If genetic testing is used to differentiate between LQT1 and LQT2 mutations, then diagnostic accuracy is improved, but cost and time consumption increase significantly

Engineering Contradiction:

Improvediagnostic accuracyVSAvoidprocessing time

Core Design Contradiction:

Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical/genetic testing system with an electrocardiographic analysis system. Instead of using genetic testing to differentiate between LQT1 and LQT2 mutations, the invention uses automated ECG parameter analysis with regression models to identify mutation types based on electrical activity patterns, thereby eliminating the time-consuming and expensive genetic testing process while maintaining diagnostic accuracy

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent changes the diagnostic parameters from genetic markers to electrocardiographic parameters. By analyzing ECG parameters such as QT interval, T-wave morphology, and repolarization patterns, the system transforms the diagnostic approach from genetic testing to electrical signal analysis, achieving rapid and accurate differentiation between LQT1 and LQT2 mutations

Inventive Principle:

Principle #35Parameter changes

2Measurement precision

If genetic testing is used to differentiate between LQT1 and LQT2 mutations, then diagnostic accuracy is improved, but cost increases significantly

Engineering Contradiction:

Improvediagnostic accuracyVSAvoidcost

Core Design Contradiction:

Measurement precisionVSEase of manufacture

Solution Approach 1:

The patent replaces the expensive genetic testing system with a cost-effective ECG analysis system. By using automated analysis of routinely available ECG data with regression models, the invention eliminates the need for costly genetic testing while maintaining the ability to accurately differentiate between LQT1 and LQT2 mutations

Inventive Principle:

Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent uses ECG signals as a surrogate or copy of genetic information. Instead of directly testing genetic material, the system analyzes electrical activity patterns that reflect the underlying genetic mutation type, providing an economical alternative that captures the essential diagnostic information without the high cost of genetic testing

Inventive Principle:

Principle #26Copying

3Ease of manufacture

If traditional ECG analysis is used, then cost is reduced, but differentiation accuracy between LQT1 and LQT2 mutations deteriorates

Engineering Contradiction:

ImprovecostVSAvoiddifferentiation accuracy

Core Design Contradiction:

Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent applies preliminary processing and feature extraction to ECG data before analysis. By pre-processing the ECG signals to extract relevant parameters such as QT interval, T-wave morphology, and repolarization patterns, and then applying regression models, the system enhances the discriminatory power of routine ECG analysis, achieving accurate differentiation between LQT1 and LQT2 mutations using cost-effective ECG data

Inventive Principle:

Principle #10Preliminary action

Solution Approach 2:

The patent introduces regression models as an intermediary between raw ECG data and diagnostic conclusions. These statistical models serve as mediators that transform routine ECG parameters into accurate predictions of mutation type, bridging the gap between simple, low-cost ECG analysis and high-precision diagnostic differentiation

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentUS7623910B2ECG-based differentiation of LQT1 and LQT2 mutation

Publication Date: 2009.11.24 UNIVERSITY OF ROCHESTER

AI summary

A method differentiating LQT1 mutation from LQT2 mutation is disclosed. An ECG signal is obtained for a patient. At least a first ECG parameter and a second ECG parameter are determined from the ECG signal. A probability that the patient is an LQT1 carrier or an LQT2 carrier is determined based on a regression model which takes into account the first ECG parameter and the second ECG parameter. A system for assessing repolarization abnormalities is also disclosed. The system has a processor configured to differentiate between LQT1 and LQT2 based on at least two ECG parameters from ECG data. The system also has a data input coupled to the processor and configured to provide the processor with the ECG data. The system further has a user interface coupled to either the processor or the data input.